These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22313648)

  • 1. Male partial hypogonadotrophic hypogonadism with gynaecomastia and metabolic syndrome.
    Ahsan T; Banu Z
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):105-7. PubMed ID: 22313648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
    Traish AM; Guay A; Feeley R; Saad F
    J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erectile dysfunction and low testosterone: cause or an effect?
    Barkin J
    Can J Urol; 2010 Feb; 17 Suppl 1():2-11. PubMed ID: 20170595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of metformin and short-term lifestyle modification on the improvement of male hypogonadism associated with metabolic syndrome.
    Casulari LA; Caldas AD; Domingues Casulari Motta L; Lofrano-Porto A
    Minerva Endocrinol; 2010 Sep; 35(3):145-51. PubMed ID: 20938417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Madelung disease: a rare case associated with gynaecomastia and scrotal involvement.
    Nikolić ZS; Jeremić JV; Drčić LJ; Rakočević ZB; Tačević ZD; Jeremić KV; Stojnić JD
    J Plast Surg Hand Surg; 2013 Oct; 47(5):415-8. PubMed ID: 23692043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging link between hypogonadism and metabolic syndrome.
    Guay AT
    J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of micropenis with strong genetic basis].
    Bolla G; Mammi I
    Pediatr Med Chir; 2013; 35(3):134-6. PubMed ID: 23947114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micropenis. III. Primary hypogonadism, partial androgen insensitivity syndrome, and idiopathic disorders.
    Lee PA; Danish RK; Mazur T; Migeon CJ
    Johns Hopkins Med J; 1980 Nov; 147(5):175-81. PubMed ID: 7441936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual function in men with metabolic syndrome.
    Lee RK; Chughtai B; Te AE; Kaplan SA
    Urol Clin North Am; 2012 Feb; 39(1):53-62. PubMed ID: 22118345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between sex hormones and the metabolic syndrome.
    Lunenfeld B
    Acta Biomed; 2010; 81 Suppl 1():79-84. PubMed ID: 20518195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases.
    Corona G; Mannucci E; Forti G; Maggi M
    Int J Androl; 2009 Dec; 32(6):587-98. PubMed ID: 19226407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
    Guay AT; Traish A
    Urol Clin North Am; 2011 May; 38(2):175-83. PubMed ID: 21621084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypogonadism and metabolic syndrome: implications for testosterone therapy.
    Makhsida N; Shah J; Yan G; Fisch H; Shabsigh R
    J Urol; 2005 Sep; 174(3):827-34. PubMed ID: 16093964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen deficiency, diabetes, and the metabolic syndrome in men.
    Kalyani RR; Dobs AS
    Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):226-34. PubMed ID: 17940444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction.
    Corona G; Mannucci E; Ricca V; Lotti F; Boddi V; Bandini E; Balercia G; Forti G; Maggi M
    Int J Androl; 2009 Dec; 32(6):720-8. PubMed ID: 19226406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erectile dysfunction and testosterone screening with prostate specific antigen screening at age 40: are these three gender specific determinants additive for overall men's heath and do they improve traditional non-gender specific determinants to lessen cardiovascular risk and all-cause mortality?
    Miner MM; Seftel AD
    Int J Clin Pract; 2010 Dec; 64(13):1754-62. PubMed ID: 21070526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome.
    Corona G; Forti G; Maggi M
    Aging Male; 2008 Dec; 11(4):193-9. PubMed ID: 19172551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypogonadotrophic hypogonadism in males. Discussion. Long-term therapeutic results].
    Guinet P; Rollet J
    Probl Actuels Endocrinol Nutr; 1973 May; 16():141-57. PubMed ID: 4200226
    [No Abstract]   [Full Text] [Related]  

  • 19. Testosterone replacement therapy in obese males.
    Drewa T; Olszewska-Słonina D; Chlosta P
    Acta Pol Pharm; 2011; 68(5):623-7. PubMed ID: 21928705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gynaecomastia with hypergonadotrophic hypogonadism and Leydig cell insufficiency in recipients of high-dose chemotherapy or chemo-radiotherapy.
    Harris E; Mahendra P; McGarrigle HH; Linch DC; Chatterjee R
    Bone Marrow Transplant; 2001 Dec; 28(12):1141-4. PubMed ID: 11803356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.